Scientists are hopeful that a new drug — called EIDD-2801 — could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. As of April 3, the novel coronavirus SARS-CoV-2 had infected more than 1 million people with…
In the wake of the novel coronavirus pandemic, Texas A&M University chemist Wenshe Ray Liu and his research team have focused their lab solely on searching for drugs to treat COVID-19. The Liu group was the first to identify the antiviral drug remdesivir as a viable medicine to treat COVID-19 in a research study published…
In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups. São José do Rio Preto is the largest city in the state’s northwestern region, with…
Below please find a summary of new coronavirus-related content published today in Annals of Internal Medicine. The summary is not intended to substitute for the full article as a source of information. A collection of coronavirus-related content is free to the public at //go.annals.org/coronavirus. 1. Neither surgical nor cotton masks effectively filter SARS…
PHILADELPHIA – Multiple sclerosis (MS), characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease. But the current treatments can hardly reverse damage that has already occurred in brain cells called neurons. New research suggests that a compound found…
PORTLAND, Ore. – Scientists have developed a precise, nanotechnology-based treatment to alleviate the pain and fertility problems associated with endometriosis, a common gynecological condition in women of childbearing age. Research led by Oleh Taratula of the Oregon State University College of Pharmacy and Ov Slayden of the Oregon National Primate Research Center at Oregon Health…
BOSTON – (April 6, 2020) – Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide. Even in children the numbers are overwhelming, with up to 80 percent of pediatric patients who are considered obese affected worldwide. People with NAFLD can…
Boston, Mass. – While the majority of people with COVID-19 won’t require hospitalization, those who do are likely to seek medical help as a result of acute respiratory distress syndrome, or ARDS, a severe lung injury common in patients with critical illnesses. At present, there is no effective treatment for ARDS other than supportive care…
Consuming a diet high in fiber was linked with a reduced incidence of breast cancer in an analysis of all relevant prospective studies. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS). Because studies have generated inconsistent results regarding the potential relationship between fiber intake and breast…
President Trump doubled down Sunday on his push for the use of an anti-malarial drug against the coronavirus, issuing medical advice that goes well beyond scant evidence of the drug’s effectiveness as well as the advice of doctors and public health experts. Mr. Trump’s recommendation of hydroxychloroquine, for the second day in a row at…